Orphan drug designation: Intellectual property safety net

被引：0
|
作者：
Emont, G [1 ]
机构：
[1] ONCOTHERAPEUT INC,BUSINESS DEV,CRANBURY,NJ 08512
来源：
BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS | 1995年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：17 / &
页数：5
相关论文
共 50 条
  • [41] Worldwide collaboration for orphan drug designation (vol 15 , pg 440, 2016)
    Mariz, Segundo
    Reese, James H.
    Westermark, Kerstin
    Greene, Lesley
    Goto, Takahiro
    Hoshino, Tatsuro
    Llinares-Garcia, Jordi
    Sepodes, Bruno
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 589 - 589
  • [42] ORPHAN DRUG DESIGNATION: A COMPARISON OF POLICIES, PROCESSES AND RESULTS FROM THE US AND THE EU
    Shields, G. E.
    Neves, Arranhado A. C.
    Bajpai, S. K.
    VALUE IN HEALTH, 2015, 18 (03) : A305 - A305
  • [43] ORPHAN DRUG DESIGNATION: NO IMPACT ON P&R PROCESS TIMING IN ITALY
    Enrici, A.
    Lidonnici, D.
    Isernia, M.
    Lanati, E.
    VALUE IN HEALTH, 2019, 22 : S716 - S716
  • [44] FDA grants orphan drug designation to thalidomide as treatment for primary brain cancers
    不详
    BIOTECHNOLOGY LAW REPORT, 1998, 17 (03): : 361 - 362
  • [45] Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseases
    Micallef, Joelle
    Blin, Olivier
    THERAPIE, 2020, 75 (02): : 133 - 139
  • [46] Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19
    Chua, Kao-Ping
    Conti, Rena M.
    JAMA INTERNAL MEDICINE, 2020, 180 (10) : 1273 - 1274
  • [47] Drug safety - Gaps in the safety net
    Couzin, J
    SCIENCE, 2005, 307 (5707) : 196 - 198
  • [48] Drug patents and intellectual property rights
    Gerard Marshall Raj
    Rekha Priyadarshini
    Jayanthi Mathaiyan
    European Journal of Clinical Pharmacology, 2015, 71 : 403 - 409
  • [49] siRNA as a new drug: intellectual property
    Schiffelers, RM
    van Kolfschoten, SC
    van Dijk, M
    Scaria, PV
    Woodle, MC
    Storm, G
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (02) : 141 - 152
  • [50] Drug patents and intellectual property rights
    Raj, Gerard Marshall
    Priyadarshini, Rekha
    Mathaiyan, Jayanthi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (04) : 403 - 409
12345